ALT $1.880.05 (2.7%)ALT Profile
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
30 Million
Altimmune Inc is a United States-based clinical stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of diseases. The firm's product candidates include NasoVAX, HepTcell, SparVax-L, NasoShield, and Oncosyn. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts.
ALT Earnings
Earnings Per Share (EPS)
-0.74
Price To Earnings Ratio (P/E)
--
1st Quarter Earnings Report
for Jan, Feb & Mar Wed, May 15, 2019 (205 days ago) Since Earnings Report -28.5%
2nd Quarter Earnings Report
for Apr, May & Jun Wed, Aug 14, 2019 (114 days ago) Since Earnings Report -11.3% ALT Dividend
Annual Dividend Yield
128.56% Annual Dividend Rate $2.42
Ex-Dividend Date
Fri, Dec 21, 2018 (350 days ago)
Dividend Pay Date
Mon, Dec 31, 2018
Dividend Payments
99 Payments (Biannual) ALT Charts
All Time High $2,100.00 Wed, Aug 8, 2007
|
| BIOTECH & PHARMA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Symbol | Price | Day | YTD |
|---|---|---|---|
| ALT | $1.88 | 2.7% | -27.7% |
Westpac Banking, Banco Santander - Chile ADS, Banco De Chile Banco De Chile ADS, National Western Life Group Inc & Tortoise Energy Infrastructure Corp..
Apple, Alphabet & JPMorgan Chase.
General Motors, Ford Motor Co, FIAT CHRYSLER AUTOMOBILES N V, Harley-Davidson Inc & Adient PLC.
